- Home
- INDV vs ZLAB Comparison
INDV vs ZLAB Comparison
Compare INDV & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- ZLAB
- Stock Information
- Founded
- INDV 1994
- ZLAB 2013
- Country
- INDV United States
- ZLAB China
- Employees
- INDV N/A
- ZLAB N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- INDV Health Care
- ZLAB Health Care
- Exchange
- INDV Nasdaq
- ZLAB Nasdaq
- Market Cap
- INDV 3.9B
- ZLAB 3.2B
- IPO Year
- INDV N/A
- ZLAB 2017
- Fundamental
- Price
- INDV $30.13
- ZLAB $21.78
- Analyst Decision
- INDV Strong Buy
- ZLAB Buy
- Analyst Count
- INDV 4
- ZLAB 6
- Target Price
- INDV $32.50
- ZLAB $57.22
- AVG Volume (30 Days)
- INDV 2.3M
- ZLAB 970.3K
- Earning Date
- INDV 10-30-2025
- ZLAB 11-06-2025
- Dividend Yield
- INDV N/A
- ZLAB N/A
- EPS Growth
- INDV 111.35
- ZLAB N/A
- EPS
- INDV 0.59
- ZLAB N/A
- Revenue
- INDV $1,180,000,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- INDV N/A
- ZLAB $40.71
- Revenue Next Year
- INDV $3.00
- ZLAB $50.42
- P/E Ratio
- INDV $51.00
- ZLAB N/A
- Revenue Growth
- INDV N/A
- ZLAB 24.14
- 52 Week Low
- INDV $7.62
- ZLAB $21.25
- 52 Week High
- INDV $32.42
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- INDV 65.90
- ZLAB 23.48
- Support Level
- INDV $30.40
- ZLAB $21.65
- Resistance Level
- INDV $31.30
- ZLAB $22.40
- Average True Range (ATR)
- INDV 1.33
- ZLAB 0.87
- MACD
- INDV 0.07
- ZLAB -0.27
- Stochastic Oscillator
- INDV 72.49
- ZLAB 8.03
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.